Expression of recombinant human soluble type ii transforming growth factor-β receptor in Pichia pastoris and Escherichia coli: Two powerful systems to express a potent inhibitor of transforming growth factor-β

Protein Expression and Purification

Volumn 12, Issue 2, 1998, Pages 201-207

  Glansbeek, Harrie L ^a   Van Beuningen, Henk M ^a   Vitters, Elly L ^a   Van Der Kraan, Peter M ^a   Van Den Berg, Wim B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; GENE EXPRESSION SYSTEM; GLYCOSYLATION; GROWTH FACTOR RECEPTOR; NEUTRALIZATION; PROTEIN FOLDING; PURIFICATION; SOLUBILIZATION; TISSUE REPAIR; TRANSFORMING GROWTH FACTOR;

ESCHERICHIA COLI; PICHIA PASTORIS;

EID: 0032029757     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1997.0819     Document Type: Article

References (30)

1. Lawrence D. A. Transforming growth factor-beta: A general review. Eur. Cytokine. Netw. 7:1996;363-374.
2. Sporn M. B., Roberts A. B. A major advance in the use of growth factors to enhance wound healing. J. Clin. Invest. 92:1993;2565-2566.
3. Nielsen H. M., Andreassen T. T., Ledet T., Oxlund H. Local injection of TGF-beta increases the strength of tibial fractures in the rat. Acta Orthop. Scand. 65:1994;37-41.
4. van Beuningen H. M., van der Kraan P. M., Arntz O. J., van den Berg W. B. In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-beta 1: Age-related differences. Ann. Rheum. Dis. 53:1994;593-600.
5. Wolf Y. G., Rasmussen L. M., Ruoslahti E. Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. J. Clin. Invest. 93:1994;1172-1178.
6. Border W. A., Noble N. A., Yamamoto T., Harper J. R., Yamaguchi Y., Pierschbacher M. D., Ruoslahti E. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature. 360:1992;361-364.
7. Czaja M. J., Weiner F. R., Flanders K. C., Giambrone M. A., Wind R., Biempica L., Zern M. A. In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis. J. Cell Biol. 108:1989;2477-2482.
8. Shah M., Foreman D. M., Ferguson M. W. Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet. 339:1992;213-214.
9. van Beuningen H. M., van der Kraan P. M., Arntz O. J., van den Berg W. B. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab. Invest. 71:1994;279-290.
10. Wahl S. M. Transforming growth factor beta (TGF-beta) in inflammation: A cause and a cure. J. Clin. Immunol. 12:1992;61-74.
11. Wrana J. L., Attisano L., Wieser R., Ventura F., Massague J. Mechanism of activation of the TGF-beta receptor. Nature. 370:1994;341-347.
12. Lin H. Y., Wang X. F., Ng Eaton E., Weinberg R. A., Lodish H. F. Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell. 68:1992;775-785.
13. Gearing A. J., Bird C. R., Bristow A., Poole S., Thorpe R. A simple sensitive bioassay for interleukin-1 which is unresponsive to 10(3) U/ml of interleukin-2. J. Immunol. Methods. 99:1987;7-11.
14. Tsang M. L., Zhou L., Zheng B. L., Wenker J., Fransen G., Humphrey J., Smith J. M., O'Connor McCourt M., Lucas R., Weatherbee J. A. Characterization of recombinant soluble human transforming growth factor-beta receptor type II (rhTGF-beta sRII). Cytokine. 7:1995;389-397.
15. Lin H. Y., Moustakas A., Knaus P., Wells R. G., Henis Y. I., Lodish H. F. The soluble exoplasmic domain of the type II transforming growth factor (TGF)-beta receptor: A heterogeneously glycosylated protein with high affinity and selectivity for TGF-beta ligands. J. Biol. Chem. 270:1995;2747-2754.
16. Tschopp J. F., Sverlow G., Kosson R., Craig W., Grinna L. High level secretion of glycosylated invertase in the methylotrophic yeast Pichia pastoris. Biotechnology. 5:1987;1305-1308.
17. Grinna L. S., Tschopp J. F. Size distribution and general structural features of N-linked oligosaccharides from the methylotrophic yeast, Pichia pastoris. Yeast. 5:1989;107-115.
18. Chaudhuri J. B. Refolding recombinant proteins: process strategies and novel approaches. Ann. N.Y. Acad. Sci. 721:1994;374-385.
19. Zhang Y., Gray R. D. Characterization of folded, intermediate, and unfolded states of recombinant human interstitial collagenase. J. Biol. Chem. 271:1996;8015-8021.
20. Futami J., Seno M., Kosaka M., Tada H., Seno S., Yamada H. Recombinant human pancreatic ribonuclease produced in E. coli: Importance of the amino-terminal sequence. Biochem. Biophys. Res. Commun. 216:1995;406-413.
21. Fischer B., Sumner I., Goodenough P. Isolation and renaturation of bio-active proteins expressed in Escherichia coli as inclusion bodies. Arzneimittelforschung. 42:1992;1512-1515.
22. Buchner J., Rudolph R. Renaturation, purification and characterization of recombinant Fab-fragments produced in Escherichia coli. Biotechnol. N.Y. 9:1991;157-162.
23. Suzuki A., Shioda N., Maeda T., Tada M., Ueno N. Cloning of an isoform of mouse TGF-beta type II receptor gene. FEBS Lett. 355:1994;19-22.
24. Goetschy J. F., Letourneur O., Cerletti N., Horisberger M. A. The unglycosylated extracellular domain of type-II receptor for transforming growth factor-beta - A novel assay for characterizing ligand affinity and specificity. Eur. J. Biochem. 241:1996;355-362.
25. Lopez Casillas F., Payne H. M., Andres J. L., Massague J. Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: Mapping of ligand binding and GAG attachment sites. J. Cell Biol. 124:1994;557-568.
26. Moustakas A., Lin H. Y., Henis Y. I., Plamondon J., O'Connor McCourt M. D., Lodish H. F. The transforming growth factor beta receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand. J. Biol. Chem. 268:1993;22215-22218.
27. O'Connor McCourt M. D., Segarubu O., Grothe S., Tsang M., Weatherbee J. A. Analysis of the interaction between two TGF-beta-binding proteins and three TGF-beta isoforms using surface plasmon resonance. Ann. N.Y. Acad. Sci. 766:1995;300-302.
28. Archer S. J., Bax A., Roberts A. B., Sporn M. B., Ogawa Y., Piez K. A., Weatherbee J. A., Tsang M. L., Lucas R., Zheng B. L., Wenker J., Torchia D. A. Transforming growth factor beta 1: Secondary structure as determined by heteronuclear magnetic resonance spectroscopy. Biochemistry. 32:1993;1164-1171.
29. Hinck A. P., Archer S. J., Qian S. W., Roberts A. B., Sporn M. B., Weatherbee J. A., Tsang M. L. S., Lucas R., Zhang B. L., Wenker J., Torchia D. A. Transforming growth factor beta 1: Three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor beta 2. Biochemistry. 35:1996;8517-8534.
30. Qian S. W., Burmester J. K., Tsang M. L. S., Weatherbee J. A., Hinck A. P., Ohlsen D. J., Sporn M. B., Roberts A. B. Binding affinity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the molecule. J. Biol. Chem. 271:1996;30656-30662.